作者

Matthew Royle, Ph.D.

合伙人

Read More

Judith Krens

合伙人

Read More

Verena Bertram

授薪合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More
作者

Matthew Royle, Ph.D.

合伙人

Read More

Judith Krens

合伙人

Read More

Verena Bertram

授薪合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More

2019年2月27日

Synapse - February 2019

This month on Synapse

SPC manufacturing waiver for export (and stockpiling)

Matthew Royle and Paul England explain the status and content of the draft SPC manufacturing for export waiver currently in the EU legislative process, including the controversial issue of the stockpiling period proposed by the EU Parliament.

Falsified Medicine Directive continued: Safety features on medicinal products and its consequences

Judith Krens and Irenah Klink explore the Delegated Regulation 2016/161, which has come into force as part of the implementation measures by the Commission in the context of the Falsified Medicine Directive (2011/62/EU).

The NHS long-term plan – The focus on technology and data

Ashley Stansfield discusses the NHS "Long Term Plan", and the implications and opportunities for businesses arising from its technology and data ambitions.

SPC for ezetimibe/simvastatin considered invalid in preliminary relief proceedings

Judith Krens and Misja Boeken discuss the Court of Appeal of the Hague case dismissing a request for a preliminary injunction based on the Dutch SPC on ezetimibe and simvastatin.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Synapse - January 2020

2020年1月16日

作者

点击此处了解更多
酒店与休闲

Synapse - December 2019

2019年12月19日

作者

点击此处了解更多
专利与创新

SPC manufacturing waiver (Part 1): You may now – yes, what actually?

2019年11月29日

作者 Verena Bertram 以及 Dr. Anja Lunze, LL.M.

点击此处了解更多